Related Experiment Video
Updated: May 14, 2026
06:45
Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
New antifungal antibiotics.
1Emergency and Intensive Care Department, Centro Hospitalar S. João, EPE, Faculdade de Medicina, University of Porto, Infection and Sepsis Group, Porto, Portugal. jarturpaiva@gmail.com
Current Opinion in Infectious Diseases
|February 16, 2013
Summary
Invasive fungal and respiratory mould infections are rising, posing significant health and economic burdens. New antifungal drugs offer improved treatment options, but careful drug selection is crucial for successful outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pharmacology
Background:
- Increasing incidence of invasive fungal infections and respiratory mould infections.
- Rising prevalence of non-Aspergillus moulds causing lung infections in specific populations.
- Emerging challenges in antifungal susceptibility and resistance.
Purpose of the Study:
- To review the evolving landscape of fungal infections.
- To discuss advancements in antifungal therapies.
- To highlight the impact of new antifungal agents on fungal epidemiology.
Main Methods:
- Review of recent literature on fungal infections and antifungal drugs.
- Analysis of trends in fungal epidemiology.
- Discussion of pharmacokinetic/pharmacodynamic properties of new antifungal agents.
Main Results:
- Significant improvements in the antifungal armamentarium over the past decade.
- Several new antifungal drugs are in development.
- New antifungal agents are influencing the epidemiology of fungal infections.
Conclusions:
- The selection of appropriate antifungal therapy is critical for clinical success.
- Consideration of the pathogen, host factors, and drug pharmacokinetics/pharmacodynamics is paramount.
- Optimizing antifungal treatment strategies is essential for managing increasing fungal infections.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...